Curbing Cancer Drug Costs: Lartruvo Vial Sizes Designed To Reduce Waste
Executive Summary
Lilly researchers used real-world data to identify a second vial size for Lartruvo that could reduce waste by nearly 87% compared to offering only a single large-size vial.
You may also be interested in...
AmerisourceBergen Oncology Drug Repackaging Program Draws $260m Fine
Now-defunct AmerisourceBergen subsidiary inappropriately repackaged oncology support drugs like Neupogen and Procrit in pre-filled syringes, violating the law and prompting safety concerns, Department of Justice announced.
Lilly's Lartruvo Scores Broad FDA Approval In Orphan Sarcomas
Accelerated filing was supported by trial of patients with 25 subtypes of soft tissue sarcoma and confirmatory study will span 50 kinds.
Cancer Drug "Oversized" Single-Dose Vials Waste Money, Need Rethinking – Article
Amgen, Takeda and Merck push back against article’s conclusions on the waste generated by current vials for infused drugs.